Merle Ferguson - 12 May 2023 Form 4 Insider Report for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Merle Ferguson
Issuer symbol
BFNH
Transactions as of
12 May 2023
Transactions value $
$0
Form type
4
Filing time
18 Oct 2023, 16:07:53 UTC
Previous filing
12 Apr 2023
Next filing
19 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFNH Common Stock Gift $0 -500K -2.95% $0.00 16.5M 12 May 2023 Shares Held in Private Company F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 15,000,000 share are held directly by the reporting individual, 1,470,000 shares held indirectly in a business entity that the reporting person is an executive officer. Total direct and indirect beneficial ownership is 16,470,000.